| INTRODUCTION
Clinicians and researchers are still searching for valid diagnostic tools to select optimal interventions and accurately predict course and outcome of early psychopathological expressions (Kapur, Philips, & Insel, 2012) . The current classification system based on the diagnostic and statistical manual of mental disorders (DSM-5, American Psychiatric Association, 2013) has, similarly to its predecessors, shortcomings in these respects (Frances & Widiger, 2012; Kendell & Jablensky, 2003; Kendler, Zachar, & Craver, 2011) . Therefore, a different perspective on psychopathology is needed, recognizing that psychological symptoms do not keep to the boundaries of diagnostic categories, do not emerge out of the blue but often develop from precursor stages, and vary greatly between individuals (McGorry, 2007; McGorry, Hickie, Yung, Pantelis, & Jackson, 2006; McGorry & van Os, 2013) . In recent years, the concept of clinical staging was introduced , promoting a subtler, more differentiated addition to the diagnostic process, studying the development of psychopathological processes in individuals. The fundamental idea of this model, developed in the context of psychosis, is that different stages of psychopathological development (ie, with increasing psychopathological severity) can be distinguished that require different types of interventions that are effective specifically in that stage .
Psychotic disorders are considered among the most severe mental disorders, in terms of both individual and societal burden (van Os & Kapur, 2009 ). Therefore, early detection and treatment of psychosis should be highly prioritized (McCrone, Patel, Knapp, & Lawton-Smith, 2008; McGorry, Killacky & Yung, 2007) . Early intervention programs for first-episode psychosis have led to the awareness that the period before onset of such a first episode is very important in light of early intervention. This period is often dubbed 'prodromal phase' retrospectively after onset of a psychotic episode (Yung et al, 2003) . However, a broad line of research has shown that its clinical picture, characterized by psychological distress, attenuated psychotic symptoms (APS) and a broad spectrum of other psychiatric symptoms, can also be identified as a prospective risk factor (Yung et al, 2003) . From this perspective, it is labelled rather as ultra high risk phase, clinical high risk phase or at risk mental state (ARMS), indicating that, although this population is at risk for developing more severe illness, adverse development is not necessarily unavoidable.
Initially, ARMS was mainly investigated as predictor of later psychotic disorder, with about 36% of the ARMS population developing a first psychotic episode within 3 years of follow-up (Fusar-Poli et al., 2012) . There is an ongoing discussion on the predictive specificity of ARMS. Although ARMS has been shown to be specific in its prediction of later psychosis (Fusar-Poli et al., 2017; Woods et al., 2018) , it has also been suggested that ARMS has additional importance as a predictor for a broader spectrum of adverse development in terms of both (persistent) non-psychotic symptomatology and impaired functioning , stressing the suggested pluripotent nature of ARMS (McGorry, Hartmann, Spooner, & Nelson, 2018) . This pluripotentiality-hypothesis implies that earlier expressions of psychopathology can be transient, persist or develop into a variety of clinical disorders (McGorry et al., 2018) . For example, early psychotic symptoms have been shown to predict the development of later psychotic disorder (Poulton et al., 2000; Welham et al., 2009 ), but also of other later (eg, mood) disorders (Addington et al., 2011; Fusar-Poli et al., 2012; Kaymaz et al., 2012; Lin et al., 2015; McGrath et al., 2016; Werbeloff et al., 2012) and/or impaired psychosocial functioning (Addington et al., 2011) . Part of these complex associations may be explained by the fact that, although the definition of ARMS currently relies heavily on positive psychotic symptomatology, presence of other symptoms (eg, anxiety, depression) is very common Lin et al., 2015) . In addition to serving as an indicator of severe mental health problems, early psychotic symptoms are also related to current and future poor functional outcome (Cotter et al., 2014 (Cotter et al., , 2018 . Both types of outcome are equally important, but are not necessarily identical: functional impairments can occur without noticeable symptomatic impairments and vice versa (Lin, Wood, & Yung, 2013; Verma, Subramaniam, Abdin, Poon, & Chong, 2012; Wunderink, Sytema, Nienhuis, & Wiersma, 2009) . OnTheROAD, the goal is to assess individuals with ARMS from a broader perspective, capturing multiple domains of psychopathology, functioning, and factors of risk and resilience. In particular, we are interested in the role of negative symptoms in ARMS (Wunderink, 2017) , as these symptoms are increasingly acknowledged as important predictors of both clinical (Pisculic et al., 2012; Demjaha, Valmaggia, Stahl, Byrne, & McGuire, 2010) and functional (Kim et al., 2013; Lin et al., 2011; 
| Sample
To meet inclusion criteria, individuals need to be aged between 
| Procedure
All new patients aged 14-35 are routinely screened online for precursor stages of psychotic symptoms with the prodromal questionnaire-16 (PQ-16; Ising et al., 2012) . Outcome of the screening procedure does not influence decisions regarding standard care for other, non-psychotic mental health complaints. In case of a sum score ≥ 6, the Comprehensive Assessment of At risk Mental States (CAARMS, Yung et al., 2005) and the Social and Occupational Functioning Assessment Scale (SOFAS, American Psychiatric Association, 1994) are assessed to determine ARMS. Based on the CAARMS interview in combination with the SOFAS, each participant is assigned to one of these three categories: (French & Morrison, 2004) and is tailored to and routinely offered to individuals with ARMS. This intervention has been shown to result in 50% reduction of the number of transitions to psychosis (from 20% to 10%) ( Van der Gaag et al., 2012; Van der Gaag et al., 2013) and has been shown to be very cost-effective (Ising et al., 2015) .
The ARMS category consists of three subgroups: a group with (a) APS, (b) brief limited psychotic symptoms (BLIPS) (ie, full-blown psychotic symptoms that resolve spontaneously within a week) and (c) schizotypal personality or a first-degree relative with psychotic history, in combination with a drop in functioning (Nelson, Yuen & Yung, 2011; Yung et al, 1996) . All three subgroups are included in OnTheROAD.
After identification of ARMS status, participants are invited to take part in OnTheROAD by a research assistant during the meeting where the CAARMS results are discussed. If interested, participants sign a written consent form. A link to the self-report questionnaires is then sending to the participant via email; interviewer-rated instruments are assessed during a face-to-face contact moment. The decision whether or not to enter OnTheRoad does not have any influence on the type of treatment that the participant receives or on any other variables. In the first stage of the project, results are not shared with participants or clinicians who are treating them. After collecting data of N = 100 participants, to aim is provide personal reports with the scores of the individual participant compared to the group level scores of the N = 100 sample that the clinician can discuss with the participant.
Standard care is offered to all participants, regardless of whether they enter OnTheRoad or not. Those who do enter OnTheROAD are invited to complete an extra assessment battery consisting of several self-report questionnaires and interviewer-rated instruments that are described in section 3.
| Ethics
Because OnTheROAD does not intervene in regular treatment, the study was exempted by the Medical Ethical Committee of the University Medical Centre Groningen (M15.173558). Written informed consent is asked from all participants older than 18 years for the use of the collected clinical data. For participants between the age of 14 and 18, written informed consent is asked from both youngster and parents. 
| Psychotic symptoms
Psychotic symptoms are assessed in a two-step procedure: first, the PQ-16 is completed. The PQ-16 consists of 16 selfrated items that are rated on a two-point scale (true/false) (14 positive psychotic symptoms and 2 negative symptoms). Items are summed.
The PQ-16 showed good concurrent validity with the interview-based CAARMS diagnoses. Using a cut-off score of six or more symptoms, Ising et al. (2012) found a high true positive rate (87%) and high specificity (87%) when differentiating UHR/psychosis from those with no CAARMS diagnosis.
When scoring above the pre-set cut-off score of ≥6, the Positive Symptom Scale of the CAARMS (Yung et al., 2005) 
| Mood, Anxiety and Stress
Mood, anxiety and stress are assessed with the Depression, Anxiety and Stress Scale-21 (DASS-21; Lovibond & Lovibond, 1995) . The DASS-21 consists of 21 self-reported items (seven per domain), rated on a four-point scale. The DASS-21 has good psychometric properties in terms of factorial structure, internal consistency and concurrent validity (Antony, Bieling, Cox, Enns, & Swinson, 1998 ).
| Mania
Mania is assessed with the self-reported Altman Self-Rating Mania Scale (ASRM; Altman, Hedeker, Peterson, & Davis, 1997). The ASRM contains five items covering several symptom domains of mania (elevated/euphoric mood, increased self-esteem, decreased need for sleep, pressured speech, and psychomotor agitation). For each item, five possible statements are given on a five-point range that represent increasing levels of mania. The ASRM has shown good psychometric properties in clinical samples, with good testretest reliability on a sample of depressed and manic patients, the ability to assess severity of manic symptoms in patients with mania and to pick up change following treatment (Altman et al., 1997) .
| Eating disorders
Symptoms of eating disorders are assessed with the SCOFF, a five item self-report questionnaire that screens for eating disorders (Morgan, Reid, & Lacey, 1999) 
| Problematic behaviour
Aggression and self-harm are assessed using an instrument that was developed for the European Long-acting Antipsychotics in Schizophrenia Trial study. Three questions were developed, based on other subscales of several other questionnaires, being the Staff Observation Aggression Scale-Revised (Nijman et al., 1999) , the Modified Overt Aggression Scale (Kay, Wolkenfield, & Murril, 1988) and the Self Harm Behaviour Questionnaire (Gutierrez, 1998) . These questions cover whether, during the past month, the participant (a) had deliberately harmed oneself, (b) had been involved in a violent incident or had been a victim of violence or (c) had attacked somebody oneself. Formal psychometric information is not yet available.
| Somatization
Symptoms of somatization are assessed with the SPHERE-12 (Hickie et al., 2001) , that included 12 self-report items from the original 34-item Somatic and Psychological Health Report (SPHERE) questionnaire. The SPHERE-12 covers six somatic (fatigue, somatic complaints) and six psychological (depression, anxiety) items on a three-point Likert scale. Combining the somatic and psychological dimensions can help to identify those patients with problems on one of these domains, on neither or on both. This system has shown to have acceptable validity and reliability (Hickie et al., 2001) .
| Alexithymia
Alexithymia, or the inability to identify and describe emotions adequately, is assessed with the Toronto Alexithymia Scale (TAS-20; Bagby, Parker, & Taylor, 1994) . The TAS-20 consists of 20 self-report items, subdivided into three subscales: difficulty with describing feelings (five items), difficulty with identifying feelings (seven items) and externally-oriented thinking (eight items), all rated on a five-point Likert scale. The TAS-20 was shown to have good internal consistency and test-retest reliability, as well as a three-factor structure that matches with the alexithymia construct (Bagby et al., 1994) .
| Clinical Global Impression
The Clinical Global Impression-Severity scale (CGI-S; Guy, 1976 ) is used to assess overall severity of illness on a seven-point scale. The interviewer rates the severity of the patient's illness at the time of assessment, relative to their previous experience with similar patients.
The CGI was shown to have good internal consistency and concurrent validity in a clinical sample (Leon et al., 1993) .
| Functioning

| SOFAS
Functioning is assessed using the Social and Occupational Functioning Scale (SOFAS; APA, 1994). The SOFAS is an interview-rated scale that gives a global assessment of the level of social and occupational functioning. Scores can range between 0 (not functioning at all) and 100 (superior functioning). In scoring the SOFAS, impact of symptoms is taken into account; therefore, this measure reflects a combination of symptomatic and functional outcomes. The lowest score in the past year is used in the current study.
| Global functioning scales
The Global functioning scales (Cornblatt et al., 2007) comprise two interviewer-rated scales that assess functioning specifically in the ARMS population: the Global Functioning Social (GF: Social) and the Global Functioning Role (GF: Role) scales. The two scales are designed along the lines of the GAF and SOFAS scales, but measure these two sub-domains separately. In addition, the scales take age and phase of illness into account. Both scales can be rated on a scale from 1 (severely disabled) to 10 (superior functioning) with each score described by an anchor. Both scales showed high interrater reliability and sensitivity to change and preliminary support for construct validity was also reported by Cornblatt et al. (2007) .
| Background factors
| Demographics
The following demographic information is obtained through selfreport: age, gender, ethnicity, relationship status, living arrangements, education, employment and sexual orientation.
| Potential risk factors
| Bonding
Bonding is assessed with the inventory for parent and peer attachment (IPPA; Armsden & Greenberg, 1987) , a 48-item self-report questionnaire that asks about bonding to the participant's mother (or mother figure) , father (or father figure) and significant other (16 items per person). Items are rated on a five-point Likert scale. The IPPA has shown to have good internal consistency, test-retest reliability and good concurrent and divergent validity (Armsden & Greenberg, 1987 ).
| Life events
Life events are assessed using the List of Threatening Experiences (LTE; Brugha, Bebbington, Tennant, & Hurry, 1985) , a self-report questionnaire that asks about 12 potential life events that may have happened during the past year, for example, having experienced serious illness or loss and that are scored as yes/no. In a clinical population, the LTE was shown to have high test-retest reliability and also good agreement with information from an external informant. Good concurrent validity was shown with a semi-structured life events interview (Brugha & Cragg, 1990 ).
| Trauma
Youth trauma is assessed using the Dutch version of the childhood trauma questionnaire (CTQ; Bernstein et al., 1994) . The CTQ is a 28-item self-report instrument that assesses the experience of five types of youth trauma (emotional abuse, physical abuse, sexual abuse, emotional neglect and physical neglect). The extent to which each type of trauma has been experienced is rated on a five-point Likert scale. The CTQ has shown high internal consistency, good test-retest reliability (interval 2-6 months) and good concurrent validity (Bernstein et al., 1994) .
| Discrimination
To assess discrimination, the same items are assessed as in the Transitions study (Purcell et al., 2015) , who adapted three questions from a scale assessing discrimination in the Quality of Life in Newly Diagnosed Epilepsy Instrument (NEWQOL; Abetz, Jacoby, Baker, & McNulty, 2000) battery.
| Family history of mental disorder
Family history of mental disorder is assessed by inquiring whether the father, mother or sibling(s) of the participant ever had any psychiatric problems. If yes, further questions on the nature of these problems and whether professional treatment was sought are probed.
| Cognitive functioning
| Neurocognition
Neurocognition is assessed using the Cambridge Neuropsychological Test Automated Battery (CANTAB, 2017; www.cantab.com) . The CANTAB is a computerized battery of tests that screens several relevant cognitive domains: memory (verbal, working and visual), spatial planning, strategy, attention flexibility, alertness and motor speed.
This often-used battery has shown to be able to adequately discriminate between healthy adults and individuals with psychiatric disorders (Egerhazi, Berecz, Bartok, & Degrell, 2007; Haring, Mottus, Koch, Trei, & Maron, 2015) .
| Social cognition
Social cognition is assessed using the Faux Pas (Stone, Baron-Cohen, & Knight, 1998) . The Faux Pas presents the participant with nine vignettes describing social situations. The participant is then asked to answer several written questions to investigate whether they recognized the faux pas in the story. The Faux Pas has shown excellent reliability in a Swedish sample (Söderstrand & Almkvist, 2012) .
| Quality of life
Following the Purcell et al. (2015) transitions study, who, in turn, 
| STATISTICAL ANALYSES
Analyses include t-test, Chi-square, Pearson/Spearman correlations, multiple linear regression and multiple logistic regression. Survival analysis will be used to predict the onset of psychotic disorder and other mental disorder, controlling for relevant covariates (including gender, age, severity of psychopathology, history of mental health care, familial history of psychopathology). Linear regression will be used to predict psychosocial outcome, controlling for relevant covariates. Multinomial logistic regression will be used for more detailed analyses, such as predicting different categories of functional outcomes (eg, working, voluntary activities, household occupations).
Dimensional assessments of psychopathology will be transformed when necessary due to non-normality. Beta coefficients, ORs and 95% confidence intervals will be calculated. OnTheROAD joins a larger movement of monitoring ARMS over time, but also has several innovative aspects. Firstly, it assesses not only psychotic symptoms as predictors of outcome, but other potentially relevant symptoms as well. This addresses in more detail the heterogeneity of ARMS and fits the idea that risk factors can be pluripotential, predicting a wider range of poor outcome. Secondly, not only onset of first psychotic disorder is investigated. On the one hand, the focus on prediction of transition to psychotic disorders as primary outcome of the ARMS trajectory has been shown to be too narrowly defined (McGorry et al., 2018; Yung et al., 2012) ; on the other hand, recent studies again suggest more specificity of prediction (Fusar-Poli et al., 2017; Woods et al., 2018) . This study will contribute to the ongoing discussion on the specificity of ARMS for predicting clinical outcome. Thirdly, the study explores a broader range of conceivable predictors of clinical and functional outcome besides positive psychotic symptoms, in particular negative symptoms.
| DISCUSSION
By means of OnTheROAD, we add to a broader development in the field that examines the pluripotentiality of ARMS. We aim to improve our understanding of the clinical picture of ARMS by taking a developmental, broader and transdiagnostic perspective and, eventually, we hope to improve clinical mental health care by providing more detailed information of individual patients' psychopathological profiles by combining insights from the clinical staging model (ie, the developmental stage of illness severity) with more personalized risk profiles based on context (ie, risk and protective factors, other patterns of co-occurring psychopathology), so that provided care can be better matched to individual needs (Wunderink, 2018) .
Recruitment of participants now takes place in mental health care services. In the future, we aim to extend recruitment also to General Practitioners, possibly using different strategies to screen subpopulations at heightened risk (Boonstra, Wunderink, Sytema, & Wiersma, 2009) . This step will also enable us to study earlier phases of the clinical staging model, as phases of developing mental illness that precede ARMS are then also captured.
